Citius Oncology, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-601.3K | $-601.3K | — | $2.0M |
| FY2024 | $126.4K | $126.4K | — | $7.5M |
| FY2025 | $-5.5M | $-5.5M | — | $8.3M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2023 | $-601.3K | $-601.3K | — | $2.0M |
| FY2024 | $126.4K | $126.4K | — | $7.5M |
| FY2025 | $-5.5M | $-5.5M | — | $8.3M |